Lv5
816 积分 2024-12-27 加入
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
1个月前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial
1个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
4个月前
已关闭
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
4个月前
已完结
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer
4个月前
已完结
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
5个月前
已完结
Reducing the Computational Complexity of EEG Source Localization With Cortical Patch Decomposition and Optimal Electrode Selection
7个月前
已完结
Celiac sprue-associated membranous nephropathy
7个月前
已完结
Nerve-sparing radical hysterectomy
7个月前
已完结
皖公网安备34019202002308
